{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:50:33Z","timestamp":1761101433976,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00520-021-06385-5","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T05:05:25Z","timestamp":1625029525000},"page":"7925-7930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxicity assessment of concurrent gabapentin\/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipients"],"prefix":"10.1007","volume":"29","author":[{"given":"Jonathan","family":"Angus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Cumpston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-7598","authenticated-orcid":false,"given":"Megan","family":"Dillaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"3","key":"6385_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejps.2008.06.015","volume":"35","author":"EM del Amo","year":"2008","unstructured":"del Amo EM, Urtti A, Yliperttula M (2008) Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci 35(3):161\u2013174","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"6385_CR2","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.bcp.2013.03.022","volume":"85","author":"D Dickens","year":"2013","unstructured":"Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, R\u00e4disch S, Hasnain SS et al (2013) Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharmacol 85(11):1672\u20131683","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"6385_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3892\/ol.2013.1342","volume":"6","author":"L Shi","year":"2013","unstructured":"Shi L, Luo W, Huang W, Huang S, Huang G (2013) Downregulation of L-type amino acid transporter 1 expression inhibits the growth, migration and invasion of gastric cancer cells. Oncol Lett 6(1):106\u2013112","journal-title":"Oncol Lett"},{"issue":"1 2","key":"6385_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijpharm.2012.12.029","volume":"443","author":"M Patel","year":"2013","unstructured":"Patel M, Dalvi P, Gokulgandhi M, Kesh S, Kohli T, Pal D, Mitra AK (2013) Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. Int J Pharm 443(1 2):245\u2013253","journal-title":"Int J Pharm"},{"issue":"7","key":"6385_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bbmt.2015.03.002","volume":"21","author":"N Shah","year":"2015","unstructured":"Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L et al (2015) Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21(7):1155\u20131166","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"6385_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2125.2007.02862.x","volume":"64","author":"CE Nath","year":"2007","unstructured":"Nath CE, Shaw PJ, Montgomery K, Earl JW (2007) Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. Br J Clin Pharmacol 64(2):151\u2013164","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"6385_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/cpt.644","volume":"102","author":"YK Cho","year":"2017","unstructured":"Cho YK, Sborov DW, Lamprecht M, Li J, Wang J, Hade EM et al (2017) Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial. Clin Pharmacol Ther 102(3):511\u2013519","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"6385_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.bbmt.2014.03.022","volume":"20","author":"J Giglia","year":"2014","unstructured":"Giglia J, White M, Hart A, Toro J, Freytes C, Holt C et al (2014) A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 20(7):1014\u20131020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"6385_CR9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00520-015-3032-y","volume":"24","author":"AJ Beijers","year":"2016","unstructured":"Beijers AJ, Vreugdenhil G, Oerlemans S, Eurelings M, Minnema MC, Eeltink CM et al (2016) Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice. Support Care Cancer 24(6):2411\u20132420","journal-title":"Support Care Cancer"},{"issue":"8","key":"6385_CR10","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00221-014-3905-1","volume":"232","author":"T Guttuso Jr","year":"2014","unstructured":"Guttuso T Jr (2014) Gabapentin\u2019s anti-nausea and anti-emetic effects: a review. Exp Brain Res 232(8):2535\u20132539","journal-title":"Exp Brain Res"},{"issue":"5","key":"6385_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","volume":"37","author":"E Puris","year":"2020","unstructured":"Puris E, Gynther M, Auriola S, Huttunen KM (2020) L-Type amino acid transporter 1 as a target for drug delivery. Pharm Res 37(5):88","journal-title":"Pharm Res"},{"key":"6385_CR12","volume-title":"Common terminology criteria for adverse events (CTCAE), v4.03","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute (2010) Common terminology criteria for adverse events (CTCAE), v4.03. National Cancer Institute, Bethesda"},{"issue":"4","key":"6385_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","volume":"88","author":"JR Mikhael","year":"2013","unstructured":"Mikhael JR, Dingli D, Roy V et al (2013) Management of newly diagnosed symptomatic multiple myeloma: updated mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88(4):360\u2013376","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6385_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00520-011-1138-4","volume":"20","author":"FM Cruz","year":"2012","unstructured":"Cruz FM, de Iracema Gomes Cubero D, Taranto P, Lerner T, Lera AT, da Costa Miranda M et al (2012) Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study. Support Care Cancer 20(3):601\u2013606","journal-title":"Support Care Cancer"},{"issue":"6","key":"6385_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1213\/01.ane.0000261517.27532.80","volume":"104","author":"EM Tiippana","year":"2007","unstructured":"Tiippana EM, Hamunen K, Kontinen VK, Kalso E (2007) Do surgical patients benefit from perioperative gabapentin\/pregabalin? A systematic review of efficacy and safety. Anesth Analg 104(6):1545\u20131556","journal-title":"Anesth Analg"},{"issue":"7","key":"6385_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/FPC.0b013e3280ea77cd","volume":"17","author":"A Kuhne","year":"2007","unstructured":"Kuhne A, Kaiser R, Schirmer M, Heider U, Muhlke S, Niere W et al (2007) Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. Pharmacogenet Genomics 17(7):505\u2013517","journal-title":"Pharmacogenet Genomics"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06385-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06385-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06385-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:36:15Z","timestamp":1635251775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06385-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06385-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board at West Virginia University Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable \u2013 research was retrospective in nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors grant final approval of the manuscript draft for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}